Try it
OBG · Gynaecological oncology: serous endometrial carcinoma
Sample itemA 72-year-old thin woman has postmenopausal bleeding, and biopsy shows high-grade serous endometrial carcinoma with strong p53 staining. Which statement describes this tumour compared with endometrioid carcinoma?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Not related to unopposed oestrogen, arises in atrophic endometrium and has a poor prognosis
Type II endometrial cancers, such as serous and clear cell carcinoma, arise in atrophic endometrium of older, non-obese women, are unrelated to oestrogen excess, and show TP53 mutations. They are aggressive with early spread, so surgical staging and adjuvant chemotherapy are used. Type I endometrioid tumours are oestrogen-related and have a better outlook.
Option by option
A. It is oestrogen dependent and has an excellent prognosis
Oestrogen dependence and good prognosis describe type I tumours.
B. It responds well to progestin therapy
Progestins are useful for well-differentiated type I tumours, not serous carcinoma.
C. It is associated with obesity and endometrial hyperplasia
Obesity and hyperplasia are features of type I disease.
D. Not related to unopposed oestrogen, arises in atrophic endometrium and has a poor prognosis (correct)
Correct. Serous carcinoma is oestrogen independent, p53 mutated and aggressive.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…
- Obstetric immunologyAn Rh-negative mother delivers an Rh-positive baby. When should anti-D immunoglobulin be…